BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27197663)

  • 1. Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients.
    Freire MP; de Oliveira Garcia D; Cury AP; Spadão F; Di Gioia TS; Francisco GR; Bueno MF; Tomaz M; de Paula FJ; de Faro LB; Piovesan AC; Rossi F; Levin AS; David Neto E; Nahas WC; Pierrotti LC
    J Antimicrob Chemother; 2016 Sep; 71(9):2577-85. PubMed ID: 27197663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-resistant Enterobacter gergoviae harbouring blaKPC-2 in Brazil.
    Almeida AC; de Castro KK; Fehlberg LC; Gales AC; Vilela MA; de Morais MM
    Int J Antimicrob Agents; 2014 Oct; 44(4):369-70. PubMed ID: 25129316
    [No Abstract]   [Full Text] [Related]  

  • 3. Outbreak of ertapenem-resistant Enterobacter cloacae urinary tract infections due to a contaminated ureteroscope.
    Chang CL; Su LH; Lu CM; Tai FT; Huang YC; Chang KK
    J Hosp Infect; 2013 Oct; 85(2):118-24. PubMed ID: 23954065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora.
    Crémet L; Bourigault C; Lepelletier D; Guillouzouic A; Juvin ME; Reynaud A; Corvec S; Caroff N
    J Antimicrob Chemother; 2012 Apr; 67(4):1041-3. PubMed ID: 22223227
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients - insights on the risk of acquisition and CRE infection.
    Freire MP; Carvalho LB; Reusing JO; Spadão F; Lopes MIBF; Nahas WC; David-Neto E; Pierrotti LC
    Infect Dis (Lond); 2021 Jun; 53(6):430-439. PubMed ID: 33612056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia.
    Novak A; Goic-Barisic I; Andrasevic AT; Butic I; Radic M; Jelic M; Rubic Z; Tonkic M
    Microb Drug Resist; 2014 Oct; 20(5):399-403. PubMed ID: 24716493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case-control-control study.
    Torres-González P; Ortiz-Brizuela E; Cervera-Hernandez ME; Bobadilla-Del Valle M; Martínez-Gamboa A; Sifuentes-Osornio J; Ponce-de-Leon A
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):243-8. PubMed ID: 27519297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
    Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
    Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of a novel Enterobacter sp. carrying blaCTX-M-15 in a neonatal unit of a tertiary care hospital in Tanzania.
    Mshana SE; Gerwing L; Minde M; Hain T; Domann E; Lyamuya E; Chakraborty T; Imirzalioglu C
    Int J Antimicrob Agents; 2011 Sep; 38(3):265-9. PubMed ID: 21752606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of carbapenem-resistant NDM-1-positive Providencia rettgeri in Mexico.
    Barrios H; Garza-Ramos U; Reyna-Flores F; Sanchez-Perez A; Rojas-Moreno T; Garza-Gonzalez E; Llaca-Diaz JM; Camacho-Ortiz A; Guzmán-López S; Silva-Sanchez J
    J Antimicrob Chemother; 2013 Aug; 68(8):1934-6. PubMed ID: 23620464
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical points and potential pitfalls of outbreak of IMP-1-producing carbapenem-resistant Pseudomonas aeruginosa among kidney transplant recipients: a case-control study.
    Freire MP; Camargo CH; Yamada AY; Nagamori FO; Reusing Junior JO; Spadão F; Cury AP; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
    J Hosp Infect; 2021 Sep; 115():83-92. PubMed ID: 34033889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei.
    Roberts LW; Harris PNA; Forde BM; Ben Zakour NL; Catchpoole E; Stanton-Cook M; Phan MD; Sidjabat HE; Bergh H; Heney C; Gawthorne JA; Lipman J; Allworth A; Chan KG; Chong TM; Yin WF; Schembri MA; Paterson DL; Beatson SA
    Nat Commun; 2020 Jan; 11(1):466. PubMed ID: 31980604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
    Netikul T; Kiratisin P
    PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the urinary tract infection caused by carbapenem-resistant Gram-negative bacilli impact the outcome of kidney transplant recipients?
    Freire MP; Mendes CV; Piovesan AC; de Paula FJ; Spadão F; Nahas WC; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Aug; 20(4):e12923. PubMed ID: 29797681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases.
    Pang F; Jia XQ; Wang B; Li YH; Zhao QG
    Pathol Biol (Paris); 2014 Jun; 62(3):152-5. PubMed ID: 24685523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?
    Schechner V; Kotlovsky T; Kazma M; Mishali H; Schwartz D; Navon-Venezia S; Schwaber MJ; Carmeli Y
    Clin Microbiol Infect; 2013 May; 19(5):451-6. PubMed ID: 22563800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010.
    Zarfel G; Hoenigl M; Würstl B; Leitner E; Salzer HJ; Valentin T; Posch J; Krause R; Grisold AJ
    Clin Microbiol Infect; 2011 Nov; 17(11):E5-8. PubMed ID: 21939472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
    Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals.
    Glupczynski Y; Huang TD; Bouchahrouf W; Rezende de Castro R; Bauraing C; Gérard M; Verbruggen AM; Deplano A; Denis O; Bogaerts P
    Int J Antimicrob Agents; 2012 Feb; 39(2):168-72. PubMed ID: 22115539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.